Emerging technologies for the clinical microbiology laboratory
BW Buchan, NA Ledeboer - Clinical microbiology reviews, 2014 - Am Soc Microbiol
In this review we examine the literature related to emerging technologies that will help to
reshape the clinical microbiology laboratory. These topics include nucleic acid amplification …
reshape the clinical microbiology laboratory. These topics include nucleic acid amplification …
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
S Broder - Antiviral research, 2010 - Elsevier
In the last 25 years, HIV-1, the retrovirus responsible for the acquired immunodeficiency
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …
FUBAR: a fast, unconstrained bayesian approximation for inferring selection
Abstract Model-based analyses of natural selection often categorize sites into a relatively
small number of site classes. Forcing each site to belong to one of these classes places …
small number of site classes. Forcing each site to belong to one of these classes places …
[HTML][HTML] 2017 update of the drug resistance mutations in HIV-1
The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last
published in November 2015. The mutations listed are those that have been identified by …
published in November 2015. The mutations listed are those that have been identified by …
Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA Panel
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …
Antiviral drug resistance of human cytomegalovirus
NS Lurain, S Chou - Clinical microbiology reviews, 2010 - Am Soc Microbiol
The study of human cytomegalovirus (HCMV) antiviral drug resistance has enhanced
knowledge of the virological targets and the mechanisms of antiviral activity. The currently …
knowledge of the virological targets and the mechanisms of antiviral activity. The currently …
[HTML][HTML] 2019 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez… - Topics in antiviral …, 2019 - ncbi.nlm.nih.gov
The 2019 edition of the IAS-USA drug resistance mutations list updates the Figure last
published in January 2017. The mutations listed are those that have been identified by …
published in January 2017. The mutations listed are those that have been identified by …
HIV-1 antiretroviral resistance: scientific principles and clinical applications
MW Tang, RW Shafer - Drugs, 2012 - Springer
The efficacy of an antiretroviral (ARV) treatment regimen depends on the activity of the
regimen's individual ARV drugs and the number of HIV-1 mutations required for the …
regimen's individual ARV drugs and the number of HIV-1 mutations required for the …
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel
MA Thompson, JA Aberg, P Cahn, JSG Montaner… - Jama, 2010 - jamanetwork.com
Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel
Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …
settings and warrant an update of recommendations to treat adults infected with human …